| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Lin,Quan | Chairman | 56.48% | TTY BIOPHARM COMPANY LIMITED |
| CARL HSIAO | Director | 56.48% | TTY BIOPHARM COMPANY LIMITED |
| Wu,Yong-Liang | Director | 56.48% | TTY BIOPHARM COMPANY LIMITED |
| Zhou,Kang-Ji | Director | 56.48% | TTY BIOPHARM COMPANY LIMITED |
| Zhou,De-Yu | Independent Director | 0.00% | |
| Chen,Rui-Xun | Independent Director | 0.00% | |
| Huang,Yao-Bin | Independent Director | 0.00% | |
| Wu,Xiu-Ming | Independent Director | 0.00% | |
| Lai,Yun-Liang | Independent Director | 0.00% |
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 287,118 | 1,115,716 | 810,917 |
| Operating cost | 136,795 | 532,954 | 411,018 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 150,323 | 582,762 | 399,899 |
| Unrealized profit (loss) on sales of goods | - | 0 | 0 |
| Realized profit (loss) on sales of goods | - | 0 | 0 |
| Operating gross profit (loss), net | 150,323 | 582,762 | 399,899 |
| Operating expenses | 107,440 | 412,906 | 336,269 |
| Other gain (loss), net | - | 0 | 0 |
| Operating profit (loss) | 42,883 | 169,856 | 63,630 |
| Non-operating income and expenses | 2,292 | 3,577 | 12,461 |
| Net profit (loss) before tax | 45,175 | 173,433 | 76,091 |
| Income tax expense (benefits) | 9,399 | 39,285 | 11,113 |
| Net profit (loss) of ongoing business for the current period | 35,776 | 134,148 | 64,978 |
| Profit (loss) of closed units | - | 0 | 0 |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 35,776 | 134,148 | 64,978 |
| Other comprehensive profit (loss), net | -18,158 | 220,230 | 39,973 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 17,618 | 354,378 | 104,951 |
| Net profit (loss) attributable to owners of parent company | 30,413 | 113,093 | 61,989 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | 0 | 3,358 |
| Net profit (loss) attributable to non-controlling interests | 5,363 | 21,055 | -369 |
| Comprehensive profit (loss) attributable to owners of parent company | 12,255 | 333,288 | 101,990 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | 0 | 3,350 |
| Comprehensive profit (loss) attributable to non-controlling interests | 5,363 | 21,090 | -389 |
| Basic earnings per share (yuan) | 0 | 2 | 1 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 26,889 | 183,768 | 33,872 |
| Net cash inflows (outflows) from investing activities | -104,620 | -110,383 | 161,017 |
| Net cash inflow (outflow) from financing activities | -2,986 | -61,685 | -107,177 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0 | 57 | -31 |
| Increase (decrease) in cash and cash equivalents in the current period | -80,717 | 11,757 | 87,681 |
| Beginning balance of cash and cash equivalents | 588,342 | 576,585 | 488,904 |
| Ending balance of cash and cash equivalents | 507,625 | 588,342 | 576,585 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 1,332,223 | 1,304,702 | 1,113,759 |
| Non-current asset | 545,537 | 537,491 | 286,100 |
| Total asset | 1,877,760 | 1,842,193 | 1,399,859 |
| Current liability | 227,227 | 208,895 | 133,626 |
| Non-current liability | 9,569 | 10,330 | 0 |
| Total liability | 236,796 | 219,225 | 133,626 |
| share capital | 383,981 | 383,981 | 383,981 |
| Equity - secruity token | - | - | - |
| capital reserve | 459,554 | 459,554 | 459,500 |
| retained earning | 511,091 | 480,678 | 208,559 |
| Other equity | 49,616 | 67,579 | 55,560 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 1,404,242 | 1,391,792 | 1,107,600 |
| Equity attributable to former owner of business combination under common control | - | 0 | 0 |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 236,722 | 231,176 | 158,633 |
| Total Equity | 1,640,964 | 1,622,968 | 1,266,233 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 36 | 36 | 28 |
